Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
DNA Mutational Analysis
Leukemia, Myeloid, Acute
We found that DNMT3A and NPM1 mutations and MLL translocations predicted an improved outcome with high-dose induction chemotherapy in patients with AML. These findings suggest that mutational profiling could potentially be used for risk stratification and to inform prognostic and therapeutic decisions regarding patients with AML. (Funded by the National Cancer Institute and others.).